Menu
Log in
Log in

News

  • Home
  • Resources
  • Literature Updates
  • Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer

Prognostic Value of Pretreatment Pathological Tumor Extent in Patients Treated With Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal or Junctional Cancer

02 Feb 2017 5:18 AM | Anonymous

Shapiro, Joel MD; Biermann, Katharina MD, PhD; van Klaveren, David MSc; Offerhaus, G. Johan A. MD, PhD; ten Kate, Fiebo J. W. MD, PhD; Meijer, Sybren L. MD, PhD; van Berge Henegouwen, Mark I. MD, PhD; Steyerberg, Ewout W. MD, PhD; Wijnhoven, Bas P. L. MD, PhD; Lanschot, J. Jan B. van MD, PhD

Click HERE for more information

Affiliated Societies



International  Interdisciplinary  Everything Esophageal


The International Society for Diseases of the Esophagus is a 501(c)3 non-profit organization. © International Society for Disease of the Esophagus – ISDE 2024 | Any unauthorized use or reproduction of the content is prohibited without explicit permission.

General Inquiries: info@isde.net
Membership Questions: membership@isde.net

Powered by Wild Apricot Membership Software